The following primary antibodies were used: anti-PPAR (Abcam, Cambridge, UK) and anti-Cyp2e1 (Millipore, US)
In this narrative review, we briefly summarize the clinical characteristics, major events, and epidemiology of high-altitude disease
Generalized linear mixed effects models were used to compare the low carnitine status with the normal carnitine status on percent change from previous timepoint in seizure frequency, seizure severity, BHB level, number of side effects, fasting triglyceride, weight and BMI, where identity links were used for normally distributed outcome
However, it is not a replacement for medical attention
The emerging roles of ferroptosis in Huntingtons Disease